Lusutrombopag: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Lusutrombopag. Educational only — not medical advice.
Labeled uses
MULPLETA is indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.
Source: FDA labeling via NIH DailyMed (set f9fd0cfd…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.